Drug Type Small molecule drug |
Synonyms Tropicamide/aceclidine, PRX 100, PRX-100 |
Target |
Action agonists |
Mechanism adrenergic receptor agonists(Adrenergic receptors agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC17H20N2O2 |
InChIKeyBGDKAVGWHJFAGW-UHFFFAOYSA-N |
CAS Registry1508-75-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Presbyopia | Phase 2 | United States | 01 Sep 2015 |
Phase 2 | 58 | (Aceclidine+Tropicamide Combination) | mshdafahwp = niwthkxeqh ewmfcljwtt (pgtftxamoj, aibdccwgfg - bedfmyzqep) View more | - | 19 Apr 2021 | ||
(Aceclidine) | mshdafahwp = lbxwvxljld ewmfcljwtt (pgtftxamoj, bnddcvslac - cerghbzvbs) View more | ||||||
NCT03201562 (Biospace) Manual | Phase 2 | 58 | Aceclidine+Tropicamide | hbucteexka(gkjoueofpn) = fapshwnoqj rldmevnsab (tlixmwrrqz ) View more | Positive | 30 Jul 2018 | |
Placebo | - |